CYT-107 | Clinical Trials, Side Effects | AIDSinfo

CYT-107 | Clinical Trials, Side Effects | AIDSinfo

CYT-107

 Other Names: IL-7, glycol-r-hIL-7, glycosylated recombinant human interleukin-7, interleukin-7, r-hIL-7, recombinant human interleukin-7, rhIL-7Drug Class: Immune ModulatorsRegistry Number: 858376-81-5 (CAS)Chemical Class: Recombinant interleukinOrganization: Cytheris SA; RevimmunePhase of Development: CYT-107 has been studied in Phase II trials for HIV treatment.

(Compound details obtained from ChemIDplus Advanced,1 Cytheris SA news release,2 Annals of Oncology article,3and Clin Infect Dis article4)